Full Text View
Tabular View
No Study Results Posted
Related Studies
Aristolochic Acid-DNA Adduct in Urothelial Carcinoma in Taiwan
This study is currently recruiting participants.
Verified February 2012 by National Taiwan University Hospital
Study NCT00867633   Information provided by National Taiwan University Hospital

First Received on March 22, 2009.   Last Updated on February 20, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Urothelial Carcinoma
Additional conditions recognized in this trial
Carcinoma
Carcinoma, Transitional Cell
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Glandular and Epithelial
Additional drug interventions recognized in this trial
Aristolochic acid I
More general drug interventions related to this trial
Anti-Infective Agents
Antiviral Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Taiwan University Hospital


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services